After treatment with GRg3, as the expression of TIGAR, NADP, GSH and G6PDH decreased, the intracellular ROS concentration further increased, which in turn induced apoptosis and served to inhibit the abnormal proliferation and differentiation of gastric mucosal epithelial cells and retard the progression of GPL to GC. The gene discussed is IL31RA; the disease is gastric cancer.